ATE15762T1 - Pharmazeutische zusammensetzungen mit gehalt an 7,8-dihydroxy-1-(hydroxy-phenyl)-2,3,4,5tetrahydro-1h-3-benzazepin-derivaten und an einem beta-adrenergischen blocker. - Google Patents

Pharmazeutische zusammensetzungen mit gehalt an 7,8-dihydroxy-1-(hydroxy-phenyl)-2,3,4,5tetrahydro-1h-3-benzazepin-derivaten und an einem beta-adrenergischen blocker.

Info

Publication number
ATE15762T1
ATE15762T1 AT81110252T AT81110252T ATE15762T1 AT E15762 T1 ATE15762 T1 AT E15762T1 AT 81110252 T AT81110252 T AT 81110252T AT 81110252 T AT81110252 T AT 81110252T AT E15762 T1 ATE15762 T1 AT E15762T1
Authority
AT
Austria
Prior art keywords
dihydroxy
blocker
hydroxy
phenyl
pharmaceutical compositions
Prior art date
Application number
AT81110252T
Other languages
English (en)
Inventor
Dennis Marvin Ackerman
Barry Alan Berkowitz
Virgil Daniel Wiebelhaus
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Application granted granted Critical
Publication of ATE15762T1 publication Critical patent/ATE15762T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT81110252T 1981-12-08 1981-12-08 Pharmazeutische zusammensetzungen mit gehalt an 7,8-dihydroxy-1-(hydroxy-phenyl)-2,3,4,5tetrahydro-1h-3-benzazepin-derivaten und an einem beta-adrenergischen blocker. ATE15762T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP81110252A EP0081006B1 (de) 1981-12-08 1981-12-08 Pharmazeutische Zusammensetzungen mit Gehalt an 7,8-Dihydroxy-1-(hydroxy-phenyl)-2,3,4,5-tetrahydro-1H-3-benzazepin-Derivaten und an einem beta-adrenergischen Blocker

Publications (1)

Publication Number Publication Date
ATE15762T1 true ATE15762T1 (de) 1985-10-15

Family

ID=8188060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81110252T ATE15762T1 (de) 1981-12-08 1981-12-08 Pharmazeutische zusammensetzungen mit gehalt an 7,8-dihydroxy-1-(hydroxy-phenyl)-2,3,4,5tetrahydro-1h-3-benzazepin-derivaten und an einem beta-adrenergischen blocker.

Country Status (18)

Country Link
US (1) US4469690A (de)
EP (1) EP0081006B1 (de)
JP (1) JPS58105921A (de)
AT (1) ATE15762T1 (de)
AU (1) AU550892B2 (de)
CA (1) CA1183777A (de)
DE (1) DE3172458D1 (de)
GR (1) GR77842B (de)
HK (1) HK11489A (de)
HU (1) HU187804B (de)
IL (1) IL67310A (de)
MY (1) MY8700934A (de)
NZ (1) NZ202510A (de)
PH (1) PH22073A (de)
PT (1) PT75915B (de)
SG (1) SG61188G (de)
ZA (1) ZA829004B (de)
ZW (1) ZW25482A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0365134A1 (de) * 1988-09-16 1990-04-25 Smithkline Beecham Corporation Synergetische Zusammensetzung eines dopaminergischen Agens und Angiotensin-Umwandlungsenzym-Inhibitoren
DE69121225T2 (de) * 1990-04-06 1997-02-06 Eisai Co Ltd Feste orale zubereitung mit einer catecholverbindung
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
EP2147679B1 (de) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Zusammensetzungen für den Blut-Hirn-Schrankentransport
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
EP2392258B1 (de) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-Informatiksystem
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
PL3395372T3 (pl) 2009-02-20 2022-07-25 EnhanX Biopharm Inc. Układ do dostarczania leków na bazie glutationu
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
DE2638716A1 (de) * 1976-08-27 1978-03-02 Ici Gmbh Antihypertensiva
US4160765A (en) * 1976-11-17 1979-07-10 Smithkline Corporation Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4265889A (en) * 1978-05-05 1981-05-05 Smithkline Corporation 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4192297A (en) * 1978-05-25 1980-03-11 Leopold Labrecque Therapeutic feet bathing device
DE2850078A1 (de) * 1978-11-18 1980-05-29 Basf Ag Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahydro-1h-1- benzazepin-2-ons
EP0022330B1 (de) * 1979-07-10 1983-12-21 Smithkline Beckman Corporation Synergistische blutdrucksenkende Zusammensetzungen

Also Published As

Publication number Publication date
PT75915B (en) 1985-11-15
PT75915A (en) 1982-12-01
HK11489A (en) 1989-02-17
SG61188G (en) 1989-07-07
PH22073A (en) 1988-05-20
ZA829004B (en) 1983-09-28
EP0081006A1 (de) 1983-06-15
EP0081006B1 (de) 1985-09-25
GR77842B (de) 1984-09-25
AU550892B2 (en) 1986-04-10
NZ202510A (en) 1985-09-13
ZW25482A1 (en) 1983-02-23
HU187804B (en) 1986-02-28
AU9084482A (en) 1983-06-16
JPS58105921A (ja) 1983-06-24
DE3172458D1 (en) 1985-10-31
US4469690A (en) 1984-09-04
IL67310A (en) 1988-09-30
CA1183777A (en) 1985-03-12
MY8700934A (en) 1987-12-31

Similar Documents

Publication Publication Date Title
IT8421343A0 (it) Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti.
DE3689252D1 (de) Arzneimittel gegen chronische Graft-versus-Host-Krankheiten sowie gegen Autoimmunerkrankungen, insbesondere systemischen Lupus erythematodes.
BR9100016A (pt) Composto,isotopo radioativo do mesmo,composicao farmaceutica,metodo de tratamento ou prevencao de estados de mamiferos
IT8467225A1 (it) Composti di solfonio, procedimento di preparazione di detti composti e composizioni farmacologiche contenenti i composti stessi.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
ATE15762T1 (de) Pharmazeutische zusammensetzungen mit gehalt an 7,8-dihydroxy-1-(hydroxy-phenyl)-2,3,4,5tetrahydro-1h-3-benzazepin-derivaten und an einem beta-adrenergischen blocker.
DE3587321D1 (de) Pharmazeutische zusammensetzungen mit gehalt an einer organo-germaniumverbindung und ihre anwendung.
IT1145403B (it) Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
IT8022357A0 (it) Composizione di carburante liquido, metodo per la preparazione di detta composizione ed emulsionante.
OA05575A (fr) Nouveaux dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
IT8221805A0 (it) Procedimento per la preparazione di copolimeri dell'etilene con basso valore delle densita'.
MX9202935A (es) Derivados de 2,3-dihidro-1h-indeno y composicion farmaceutica que los contiene.
ES516603A0 (es) "procedimiento para la preparacion de resinas epoxidicas avanzadas".
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
IT8121654A0 (it) Derivati tiazolidinici ad attivita' farmacologica, procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati.
IT8349419A0 (it) Derivati triazinici dotati di attivita' analgesica, antipiretica ed antiinfiammatoria
IT8224575A0 (it) Derivati dell'azolil-pentene procedimento di preparazione ditali composti e mezzi biocidi contenenti gli stessi.
IT8119758A0 (it) Derivati 2'-deossi-3',5'-di-o-alchilcarbonil-5-fluorouri dinici processo per la loro preparazione e agenti antitumorali che contengono i detti derivati.
IT8323010A0 (it) Derivati 15-cicloalifatici di 13,14-dideidro carboprostacicline eprocedimento per la loro preparazione.
ES518725A0 (es) Procedimiento de preparacion de nuevos derivados del azabiciclo (3.2.0) heptano.
IT8219900A0 (it) Composto chemioterapico, procedimento per la sua preparazione e relative composizioni farmaceutiche.
ATE50995T1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
ATE18994T1 (de) Neue pharmazeutische zusammensetzung.
FI813201A7 (fi) Menetelmä 4-okso-3,4-dihydro-2H-1,2- bentsotiatsiini-1,1,- dioksidi-3-karboksiamidi-johdannaisten valmistamvalmistamiseksi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee